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ABSTRACT 22 
RNA remodeling proteins, including RNA helicases and chaperones, act to 23 
remodel RNA structures and/or protein-RNA interactions, and are required for all 24 
processes involving RNAs. Although many viruses encode RNA helicases and 25 
chaperones, their in vitro activities and their roles in infected cells largely remain 26 
elusive. Noroviruses are a diverse group of positive-stranded RNA viruses in the 27 
family Caliciviridae, and constitute a significant and potentially fatal threat to human 28 
health. Here we report that protein NS3 encoded by human norovirus has both 29 
ATP-dependent RNA helicase activity that unwinds RNA helices and 30 
ATP-independent RNA chaperoning activity that can remodel structured RNAs and 31 
facilitate strand-annealing. Moreover, NS3 can facilitate viral RNA synthesis in vitro 32 
by norovirus polymerase. NS3 may therefore play an important role in norovirus RNA 33 
replication. Lastly, we demonstrate that the RNA remodeling activity of NS3 is 34 
inhibited by guanidine hydrochloride, an FDA-approved compound and, more 35 
importantly, that it reduces the replication of norovirus replicon in cultured human 36 
cells. Altogether, these findings are the first to demonstrate the presence of RNA 37 
remodeling activities encoded by Caliciviridae, and highlight the functional 38 
significance of NS3 in noroviral life cycle.  39 
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IMPORTANCE 41 
Noroviruses are a diverse group of positive-stranded RNA viruses, which 42 
annually cause hundreds of millions of human infections and over 200,000 deaths 43 
worldwide. For RNA viruses, cellular or virus-encoded RNA helicases and/or 44 
chaperones have long been considered to play pivotal roles in viral life cycles. 45 
However, neither RNA helicase nor chaperoning activity has been demonstrated to 46 
associate with any norovirus-encoded proteins, and it is also unknown whether 47 
norovirus replication requires the participation of any viral or cellular RNA 48 
helicases/chaperones. We found that a norovirus protein NS3 not only has 49 
ATP-dependent helicase activity, but also acts as an ATP-independent RNA chaperone. 50 
And NS3 can facilitate in vitro viral RNA synthesis, suggesting the important role of 51 
NS3 in norovirus replication. Moreover, NS3 activities can be inhibited by an 52 
FDA-approved compound, which also suppresses norovirus replicon replication in 53 
human cells, raising the possibility that NS3 could be a target for anti-noroviral drug 54 
development. 55 
 56 
  57 
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INTRODUCTION 58 
Noroviruses are a genetically diverse group of non-enveloped, positive-stranded 59 
RNA viruses belonging to genus Norovirus of the family Caliciviridae. They are 60 
further segregated into seven genogroups (GI-GVII), three of which cause diseases 61 
exclusively in humans (GI, GII, and GIV) (1-3). Human noroviruses (HuNoVs) are 62 
now considered the leading cause of viral gastroenteritis in humans across the globe. 63 
HuNoV infections are estimated to cause 684 million of cases of diarrheal disease, 1.1 64 
million hospitalizations and 212 000 deaths worldwide, with an economic burden of 65 
~60 billion dollars per year (4, 5). They are highly contagious, infecting people of all 66 
ages, with higher incidence in young children and low-income settings (4, 5). 67 
Although HuNoV infections are usually acute and self-limiting with low mortality, 68 
they often cause chronic or life-threatening infections and symptoms in 69 
immunocompromised patients and the elderly (6). As a result of their high infectivity, 70 
stability and resistance to common sanitizers, HuNoV has also been classified as 71 
Category B biodefense agents (6, 7). However, despite its substantial burden and 72 
potential threat, there is still no vaccines or antiviral drugs available to prevent or treat 73 
norovirus infection (4, 5, 8).  74 
The noroviral genomic RNA is 7.4-7.7 kb in length and typically organized into 75 
three open reading frames (ORF1-3) (8). Exceptionally, the GV murine norovirus 76 
(MNV) has an additional ORF (ORF4) encoded within ORF2 (9, 10). The 5´ proximal 77 
ORF1 encodes a large polyprotein that is cleaved by a norovirus-encoded protease 78 
(NS6
Pro
) into at least six mature nonstructural proteins, while the 3´ proximal region 79 
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of noroviral genomic RNA is transcribed into a subgenomic RNA that contains ORF2 80 
and ORF3 that encode the major and minor structural proteins VP1 and VP2, 81 
respectively (Fig. 1A). Although these viruses have been extensively studied for 82 
decades, our understanding about the mechanisms of the nonstructural proteins 83 
involved in norovirus replication is very limited, particularly in comparison to other 84 
positive-stranded RNA viruses such as picornaviruses and flaviviruses.  85 
For many RNA viruses, the viral RNA (vRNA) contains multiple cis-acting 86 
elements that play pivotal roles in vRNA replication, translation and encapsidation, 87 
during the viral life cycle (11-13). As with cellular RNA molecules, these elements are 88 
often highly structured in vRNAs and must be folded into the correct tertiary 89 
structures to be functional. However, this can be problematic because RNAs can be 90 
easily trapped in stable but misfolded intermediate states (14, 15). To avoid this, cells 91 
and viruses encode a variety of RNA remodeling proteins, such as RNA helicases and 92 
RNA chaperones, which can destabilize RNA-RNA or RNA-DNA duplexes to 93 
promote the proper folding or re-folding of RNAs (16-18). In addition, viral or 94 
cellular RNA helicases are thought to participate the unwinding of viral replicative 95 
intermediate double-stranded RNAs (vRI-dsRNAs) formed during vRNA replication, 96 
thereby allowing recycling of vRNA templates for further rounds of vRNA synthesis. 97 
RNA helicases have nucleoside triphosphatase (NTPase) activity, using the energy of 98 
NTP binding and/or hydrolysis to unwind RNA duplexes, and are believed to 99 
participate in most ATP-dependent rearrangement of structured RNAs (19). RNA 100 
chaperones are a heterogeneous group of proteins that can destabilize RNA duplexes 101 
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and promote correct RNA folding in an ATP-independent fashion (20). A wide range 102 
of RNA viruses, including flavivirus (21), picornavirus (22), alphavirus (23), 103 
coronavirus (24), reovirus (25), iflavirus (26), and alphatetravirus (27) have been 104 
found to encode their own RNA helicases and/or RNA chaperones (28).  105 
Sequence analysis showed that the norovirus NS3 protein, also known as p41, 106 
contains signature motifs that are conserved in superfamily-3 (SF3) viral helicases 107 
such as the human enterovirus 2C
ATPase 
(EV71 2C
ATPase
)
 
(22), simian virus 40 (SV40) 108 
large T antigen (LTag) (29), adeno-associated virus 2 (AAV2) Rep40 (30, 31), and the 109 
human papillomavirus 18 (HPV18) E1 protein (32) (Fig. 1). Consistent with this 110 
observation, the NS3 protein encoded by Southampton virus (SHV), a GI HuNoV, has 111 
been shown to have a NTPase activity (33). In addition, norovirus NS3 has been 112 
recently reported to associate with vRI-dsRNAs in viral replication complex (vRC) 113 
and to induce vesicular structures (34-36). However, previous work has yet to 114 
demonstrate RNA helicase or chaperoning activity associated with NS3 or any other 115 
norovirus- or calicivirus-encoded proteins, or that the replication of norovirus or 116 
calicivirus requires the participation of any viral or host RNA remodeling activities. 117 
This gap hampers our understanding about the replication mechanisms of this large 118 
group of medically important human pathogens, as well as the development of 119 
anti-noroviral drugs that may specifically target viral RNA helicase/chaperoning 120 
activities. 121 
Our previous work on enterovirus 2C
ATPase
 revealed that, in vitro, 2C
ATPase
 has 122 
RNA remodeling activity when expressed using a baculovirus-based expression 123 
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system (22). Here, we show that NS3 encoded by Norwalk virus (NV; genotype GI.1 124 
HuNoV), the prototype strain of the genus Norovirus, also has NTP-dependent RNA 125 
helicase activity. Moreover, we demonstrate that NS3 can also act as an RNA 126 
chaperone that is able to remodel structured RNAs and facilitate strand annealing 127 
independently of NTP. We have also found that NS3 can facilitate the in vitro 128 
synthesis of vRNA by NV NS7/RNA-dependent RNA polymerase (RdRP) on the 3´ 129 
antigenomic template, suggesting that NS3 plays important role in norovirus RNA 130 
replication. Additionally, we have demonstrated that the guanidine hydrochloride 131 
(GuHCl), which is a U.S. FDA-approved small molecule drug and a well-known 132 
inhibitor of poliovirus 2C
ATPase
, is able to inhibit the RNA helicase activity of NS3 in a 133 
dose-dependent manner. More importantly, GuHCl has been further determined to 134 
inhibit the replication of NV replicon in cultured human cells, which highlights the 135 
functional significance of NS3 in noroviral life cycle. 136 
 137 
  138 
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RESULTS 139 
NV NS3 shares similar consensus motifs and structure with other SF3 viral 140 
helicases 141 
A comparison of the amino acid sequence of NV NS3 with members of the SF3 142 
viral helicases, including EV71 2C
ATPase
, AAV2 Rep40, SV40 LTag, and HPV18 E1, 143 
revealed that NV NS3 contains the conserved SF3 helicase A, B, and C motifs (Fig. 144 
1B). 145 
Since the three-dimensional (3D) structure of norovirus NS3 has not yet been 146 
reported, we modeled the NV NS3 structure using the ROBETTA server for protein 147 
structure prediction and analysis (37). The predicted model of the NV NS3 revealed 148 
that the C-terminal two thirds consisting of amino acids (a.a) at positions 122-363 (i.e. 149 
NS3ΔN) is comprised of two structurally independent domains; a helicase core (HC; 150 
a.a. 122-288) forming a central five-stranded β-sheet sandwiched by α helices on both 151 
sides, and the C-terminal domain (CTD; a.a. 289-363) comprising of several α helices. 152 
These domains are linked by flexible loops (Fig. 1C), and interestingly, demonstrates 153 
some limited similarity with the counterpart region of EV71 2C
ATPase
 (22). Moreover, 154 
the predicted SF3 motifs A, B, and C of NV NS3 are nicely overlapped with the 155 
conserved SF3 motifs in these other SF3 viral helicases (Fig. 1D-F).  156 
 157 
NV NS3 contains NTPase activity  158 
Previous studies by Pfister and Wimmer found that bacterially expressed 159 
Southampton virus (SHV) NS3 has NTPase activity (33). To confirm whether NV 160 
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NS3 also has this activity, we expressed recombinant Maltose binding protein 161 
(MBP)-fusion NV NS3  using a baculovirus expression system , and then examined 162 
the NTPase activity by incubating MBP-NS3 with different NTPs. The hydrolysis of 163 
NTP was measured using a sensitive colorimetric assay that determines the total 164 
amount of released inorganic phosphate. As found for SHV NS3, our data showed that 165 
NV NS3 hydrolyzed all four types of NTPs (Fig. 2A). However, although SHV NS3 166 
was reported to hydrolyze UTP less well than ATP (33), NV NS3 exhibited similar 167 
efficiency in the hydrolysis of these NTPs (Fig. 2A). 168 
To further characterize the NTPase activity of NV NS3, we assessed the ATPase 169 
activity of MBP-NS3 under different of ATP and Mg
2+
 concentrations as well as at 170 
different pH, as ATP is the major energy source in cells. Our results showed that the 171 
amount of hydrolyzed ATP was increased with increasing amounts of ATP (Fig. 2B). 172 
In addition, our data indicates that the ATPase activity of MBP-NS3 is 173 
Mg
2+
-dependent, since its ATP hydrolyzing activity was undetectable in absence of 174 
Mg
2+
. Whilst the ATPase activity of MBP-NS3 was found to be optimal at 2 mM 175 
Mg
2+
 concentration, higher levels of Mg
2+
 inhibited the ATPase activity (Fig. 2C). The 176 
optimal pH for MBP-NS3 ATPase activity was found to be ~pH 7.6, but broad activity 177 
was maintained between pH 6.8 and pH 8.0 (Fig. 2D). 178 
We also expressed MBP-fusion NV NS3 using E. coli, and examined its NTPase 179 
activity. We confirmed that the bacterially expressed MBP-NS3NV can also hydrolyze 180 
ATP and other NTPs and shows similar biochemical properties with the eukaryotically 181 
expressed MBP-NS3NV (data not show). Altogether, our data demonstrate that similar 182 
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to SHV NS3, the NV NS3 has an NTPase activity that hydrolyzes all four NTPs and is 183 
Mg
2+
-dependent. 184 
 185 
NV NS3 has nucleic acid helix unwinding activity  186 
To assess the potential helix unwinding activity of NV NS3, we annealed a short 187 
hexachloro fluorescein (HEX)-labeled RNA and a longer unlabeled RNA to generate 188 
a standard RNA helix substrate with both 5´- and 3´-single stranded protrusions (Fig. 189 
3A and Table 1). The helix unwinding assay was performed by incubating the 190 
standard RNA helix substrate with purified MBP-NS3 in the standard unwinding 191 
reaction and then the substrate was evaluated via gel electrophoresis. As shown in Fig. 192 
3A, the HEX-labeled RNA strand was released from the RNA helix substrate in the 193 
presence of MBP-NS3, whereas the RNA helix substrate remained annealed when 194 
MBP alone was added as a mock helicase, showing that NV NS3 can unwind the 195 
RNA helix. The reactions were performed in the presence of ATP and MgCl2. The 196 
boiled helix substrate or the addition of MBP-fusion EV71 2C
ATPase
 were used here 197 
and in subsequent experiments as relevant controls for helix unwinding activity. 198 
Because some viral RNA helicases have been reported to unwind DNA helices or 199 
RNA-DNA hybrids (22), we sought to examine if NV NS3 can unwind nucleic acid 200 
helices containing DNA. For this purpose, we constructed three helix substrates: a 201 
DNA duplex (D*/D; Fig. 3B), an RNA-DNA hybrid with a longer unlabeled RNA 202 
(D*/R; Fig.. 3C) or DNA strand (R*/D; Fig. 3D). Each helix substrate was reacted 203 
with MBP-NS3 under the same condition as in Fig. 3A, and our results showed that 204 
 o
n
 M
arch 23, 2018 by CAM
BRIDG
E UNIVERSITY LIBRARY
http://jvi.asm.org/
D
ow
nloaded from
 
11 
 
NV NS3 can efficiently unwind either of the RNA-DNA hybrids (Fig. 3C and 3D), 205 
but unwound the DNA duplexes less effectively (Fig. 3B).  206 
We further evaluated the RNA helix unwinding activity of MBP-NS3 under 207 
different conditions. We observed that the helix unwinding activity of MBP-NS3 can 208 
be promoted by the presence of NTP, particularly ATP or GTP (Fig. 4B), indicating 209 
that NV NS3 has an RNA helicase activity. Consistent with the characterization of 210 
NS3 NTPase activity (Fig. 2C and D), the optimized helix unwinding activity of 211 
MBP-NS3 was found around 2 mM Mg
2+
 (Fig. 4C) at pH value of around 7.6 (Fig. 212 
4D). Collectively, these findings suggest that the NV NS3 has an NTP-dependent 213 
nucleic acid helix unwinding activity. 214 
 215 
NV NS3 directs the RNA helix unwinding from both 5´→3´ and 3´→5´ directions 216 
The directionality of helix unwinding is a fundamental characteristic of helicases 217 
(19). Previous studies of other SF3 viral helicases have revealed that the helicase 218 
activity of EV71 2C
ATPase
 has a 3´→5´ directionality, while AAV2 Rep40 and HPV18 219 
E1 unwind helices bidirectionally (22, 31, 32). To determine the unwinding 220 
directionality of NV NS3, we generated two different RNA helix substrates: one 221 
containing a 5´ single-stranded protrusion (Fig. 5A), and the other with a 3´ 222 
single-stranded protrusion (Fig. 5B). Each substrate was subjected to helix unwinding 223 
assay in the presence of MBP-NS3. Our data showed that RNA helix substrates with 224 
either a 5´- or a 3´-protrusion could be unwound by MBP-NS3 (Fig. 5C). Moreover, 225 
the unwinding of either substrate by MBP-NS3 can be promoted by the presence of 226 
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ATP in a dose-dependent manner (Fig. 5D and E). Based on these observations, we 227 
conclude that NV NS3 directs the unwinding of RNA helix from both 5´→3´ and 228 
3´→5´ directions in an ATP-dependent manner, similar to AAV2 Rep40, another SF3 229 
viral helicase (22, 31, 32). 230 
 231 
The conserved SF3 motif A is critical for the helicase activity of NS3 232 
The sequence analysis of NS3 indicates that NS3 contains consensus motifs that 233 
are characteristic of SF3 viral helicases (Fig. 1). The motif A has been recognized as a 234 
core element of the NTP binding and NTPase active site of SF3 helicases (19) and is 235 
conserved in different noroviruses (Fig. 6A). Previous work by Pfister et al. has 236 
shown that the mutation of motif A in SHV NS3 almost completely eliminated its 237 
ATPase activity (33). Moreover, motif B of SF3 helicases has been reported to 238 
chelates Mg
2+
 (19). We wanted to investigate if the conserved SF3 motif A or B is 239 
important for the helicase activity associated with norovirus NS3. To this end, we 240 
generated the GK168AA and GK168AA-DD212AA mutants of MBP-fusion NS3 241 
(MBP-NS3GK168AA and MBP-NS3GK168AA-DD212AA) and expressed the proteins using 242 
the baculovirus expression system. In our standard helix unwinding assays we found 243 
that both of the GK168AA and GK168AA-DD212AA mutations dramatically reduced 244 
the helix unwinding activity of NS3 compared to wild-type (Fig. 6B). Moreover, the 245 
addition of increasing concentrations of ATP had very little effect on helix unwinding 246 
by MBP-NS3GK168AA (Fig. 6C). These findings determine that the conserved SF3 247 
motifs are critical for the helicase activity of NS3. 248 
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 249 
NV NS3 also possesses an NTP-independent RNA chaperoning activity 250 
Although we have determined that NV NS3 requires NTP to reach its optimal 251 
helix unwinding activity (Fig. 4B, 5D, and 5E) and that the conserved SF3 motif A is 252 
critical for its helicase activity (Fig. 6), we found that a portion of the helical RNA 253 
substrate could still be unwound by MBP-NS3 in the absence of ATP (Fig. 4B, 5D, 254 
and 5E). To confirm these observations and exclude the possible interference of trace 255 
amounts of NTP in the unwinding assays, we alternatively used AMP-PNP, an ATP 256 
analog that is non-hydrolysable and able to block NTPase activity. The incorporation 257 
of 5 mM AMP-PNP, instead of ATP or other NTPs, did not completely abolish the 258 
RNA helix unwinding by MBP-NS3 (Fig. 7A). Whilst both the RNA helicases and 259 
RNA chaperones possess RNA remodeling activities, and the fundamental difference 260 
between them is that the former activity requires the participation of NTP, whereas the 261 
latter is NTP-independent (20). These observations therefore suggest that NV NS3 262 
also contains an NTP-independent RNA chaperoning activity. 263 
RNA chaperones are generally thought to destabilize misfolded RNA secondary 264 
structures to facilitate the re-formation of more stable RNA structures (15). To further 265 
characterize the RNA chaperoning activity of NV NS3, we adapted a canonical assay, 266 
which evaluates the helix-destabilizing and annealing acceleration activities of RNA 267 
chaperones (38). In this assay, we designed and generated two 42-nt complementary 268 
RNA strands, each of which forms a defined stem-loop secondary structure; in 269 
addition, one strand is 5’-HEX labeled and the other is unlabeled, as indicated in 270 
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Fig. 7B. Equal amounts of the two strands were mixed and incubated in the presence 271 
or absence of MBP-NS3, and the hybridization of the two strands were then 272 
determined using gel shift assay. In these reactions, ATP or other NTPs were not 273 
supplemented. Our data showed that the levels of the annealed hybrids were gradually 274 
increased with the increasing amounts of MBP-NS3 (Fig. 7C). Moreover, although 275 
minimal spontaneous hybridization could be observed in the absence of MBP-NS3 276 
with prolonged incubation time (Fig. 7D, lanes 3-6), the addition of MBP-NS3 further 277 
enhanced the hybridization at each time points (Fig. 7D, lanes 7-10). Altogether, our 278 
results show that NV NS3 can destabilize structured RNAs and facilitate the 279 
formation of a more stable RNA structure, confirming that NV NS3 is also a 280 
NTP-independent RNA chaperone. 281 
 282 
NV NS3 promotes noroviral RNA synthesis in vitro 283 
For positive-stranded RNA viruses, their RdRP-mediated vRNA replications 284 
generate viral replicative intermediate double-stranded RNAs that could be unwound 285 
by RNA helicases in order to recycle vRNA templates (39). Virus-encoded RNA 286 
chaperones may help rearrange the structured RNA elements of vRNA templates, 287 
thereby facilitating vRNA synthesis (25). After determining the RNA helicase and 288 
chaperoning activities of NV NS3, we wanted to evaluate the potential role of NS3 in 289 
norovirus RNA replication. As illustrated in Fig. 8A, we incubated a recombinantly 290 
purified MBP-fusion HuNoV NS7/RdRP protein with in vitro transcribed RNA 291 
corresponding to the 400 nts at the 3´-end of HuNoV antigenomic (-)-vRNA, which is 292 
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presumably the template for the initiation of (+)-vRNA synthesis, in the presence or 293 
absence of WT or GK168AA mutant MBP-NS3. The reaction was not supplemented 294 
with an oligonucleotide RNA primer as noroviral RNA synthesis can occur 295 
primer-independently, at least in vitro (40). And the newly synthesized RNA was 296 
detected by Northern blots using the probe specific for (+)-vRNA. Here, we observed 297 
that the presence of WT MBP-NS3 promoted the NS7/RdRP-mediated production of 298 
(+)-vRNA strands from the (-)-vRNA templates, and that the promoting effect of NS3 299 
could be further enhanced with increasing the reaction time (Fig. 8B and 8C). On the 300 
other hand, the motif A mutation mostly eliminated the promoting effect of MBP-NS3 301 
on in vitro RNA synthesis (Fig. 8D and 8E). 302 
 303 
GuHCl inhibits the NTPase and RNA helix unwinding activities of NV NS3 304 
Previous studies have reported that the NTPase and RNA helicase activities of 305 
enterovirus 2C
ATPase
 can be inhibited by GuHCl (22, 41-45), which also inhibits 306 
replication of vRNA of a number of enteroviruses (46, 47). Given the similarity 307 
between the consensus motifs in enterovirus 2C
ATPase
 and norovirus NS3, we wanted 308 
to examine whether NV NS3 could also be a target for guanidine inhibition. NTPase 309 
assays showed that GuHCl inhibited the ATPase activity of NV NS3 in a 310 
dose-dependent manner (Fig. 9A). This result is in contrast with the previous 311 
observation by Pfister and Wimmer who demonstrated that even in the presence of up 312 
to 10 mM GuHCl, the ATPase activity of SHV NS3 was not inhibited (33). This 313 
contrasting results might be due to the different expression strategies (eukaryotic vs. 314 
 o
n
 M
arch 23, 2018 by CAM
BRIDG
E UNIVERSITY LIBRARY
http://jvi.asm.org/
D
ow
nloaded from
 
16 
 
prokaryotic) or the inherent biochemical properties of two NS3 proteins, which were 315 
also shown to have different hydrolysis preferences for UTP (Fig. 2A) and different 316 
responses to Mg
2+
 concentrations higher than 2 mM (Fig. 2C). 317 
To examine if GuHCl could also inhibit the helix unwinding by NV NS3, the 318 
helix unwinding reactions were performed in the presence of NS3 and increasing 319 
concentrations of GuHCl. Our results showed that the presence of GuHCl inhibited 320 
the helix unwinding by NS3 in a dose-dependent manner (Fig. 9B and C). Intriguingly, 321 
we examined the effect of GuHCl on the RNA chaperoning activity of NV NS3 using 322 
the RNA strand hybridization assay. Our data showed that the addition of GuHCl at 323 
different concentrations had no obvious effect on NS3 RNA chaperoning activity (Fig. 324 
9D). 325 
It is important to note that the helicase activity and ATPase activity show similar 326 
sensitivities to GuHCl, and the inhibitory effects due to GuHCl on helicase and 327 
ATPase activities of NV NS3 are moderate, but similar to the effects observed in 328 
EV71 2C
ATPase
 (22). Nevertheless, these data demonstrate that GuHCl is an inhibitor 329 
of the key biochemical activities of NV NS3. 330 
 331 
GuHCl inhibits NV replication in cultured human cells 332 
Whilst we have shown that GuHCl can inhibit the NTPase and helix unwinding 333 
activities of NV NS3, we sought to determine whether GuHCl treatment can inhibit 334 
HuNoV replication in cells. To this end, the effect of GuHCl on HuNoV replication 335 
was evaluated by using the NV replicon system in cultured human gastric tumor 336 
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(HGT-1) cells. The levels of NV RNA in the presence of GuHCl at different 337 
concentrations were determined by real-time quantitative reverse transcription-PCR 338 
(qRT-PCR), and the expression levels of NV proteins were determined by western 339 
blotting of NV NS3. 2´-C-methylcytidine (2CMC), a nucleoside analog that has been 340 
reported to inhibit HuNoV replication (48, 49), was used as the positive control. As 341 
shown in Fig. 9E, the presence of 1.125 mM GuHCl significantly reduced the level of 342 
NV RNA to around 50% of that under mock treatment, while increasing the GuHCl 343 
concentration to 3.25 mM only moderately enhanced the inhibitory effect of GuHCl 344 
to NV RNA replication. As expected, 2CMC showed a strong inhibitory effect on NV 345 
RNA replication (Fig. 9E). We also showed that the presence of 1.125 or 3.25 mM 346 
GuHCl did not affect the viability of HGT-1 cells, as found for 2CMC treated cells, 347 
excluding the possibility that the inhibitory effect of GuHCl on NV RNA replication 348 
was due to inducing cell death (Fig. 9F). Hence, GuHCl can inhibit the replication of 349 
NV replicon at 1.125 mM in cultured human cells without apparent cytotoxicity. 350 
  351 
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DISCUSSION 352 
During the life cycle of RNA viruses, cellular or virus-encoded RNA helicases or 353 
chaperones are believed to facilitate correct folding or unfolding of RNA structures or 354 
to separate vRI-dsRNAs for more rounds of vRNA replication (14, 15, 22). Here we 355 
report for the first time that NV-encoded NS3 has both NTP-dependent RNA helicase 356 
and NTP-independent RNA chaperoning activities that can unwind RNA helices, and 357 
destabilize and remodel structured RNA molecules. Moreover, we have found that 358 
NS3 can stimulates NS7/RdRP-mediated noroviral RNA synthesis in vitro, suggesting 359 
that NS3 plays an important role in norovirus RNA replication. Our work has also 360 
shown that GuHCl, an FDA-approved small molecule drug, can inhibit the RNA 361 
helicase activity of NS3 in vitro, and more importantly, that this small molecule has 362 
some inhibitory activity against replication of a HuNoV replicon in cultured human 363 
cells. 364 
The RNA remodeling activities of viral proteins are generally believed to play 365 
important roles in viral life cycles (50). For instance, during vRNA replication of 366 
RNA viruses, vRI-dsRNAs must be efficiently unwound, thereby releasing nascently 367 
synthesized progeny vRNAs from vRNA templates. Moreover, viral genomic and 368 
antigenomic RNAs contain multiple cis-acting elements, highly structured RNA 369 
regions that usually play pivotal roles in the replication, translation, and encapsidation 370 
of vRNAs (11, 51). Sometimes, a specific RNA structure required for one vRNA 371 
function, like translation or encapsidation, may need disruption and refolding to 372 
facilitate another vRNA function, like vRNA replication, and vice versa. For example, 373 
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genomic RNAs or mRNAs of some RNA viruses, including norovirus (13, 52, 53), 374 
flavivirus (12), hantavirus (54), and reovirus (55), can undergo circularization, 375 
resulting in the base-pairing of vRNA 5´- and 3´-ends to form panhandle-like 376 
structures that may facilitate vRNA translation, encapsidation, or RdRP recruitment to 377 
3´-end of vRNAs (51, 56). However, for initiation of RNA replication, these cyclized 378 
vRNA structures need to be disrupted to make the 3´-end of vRNAs accessible by 379 
RdRPs; an example of this type of activity is the chaperoning effect of cypovirus VP5 380 
on cyclized cypoviral mRNAs (25). Viral RNA remodeling proteins may also 381 
dynamically facilitate proper folding and unfolding of different vRNA structures, 382 
thereby allowing vRNAs to switch among distinct functionalities. 383 
For noroviruses, it has been found that their vRNAs contain multiple cis-acting 384 
elements and RNA secondary structures, which are important for norovirus replication 385 
(13, 51-53). With that in mind it is intriguing that we have observed ability of NS3 to 386 
enhance NS7/RdRP-mediated noroviral RNA synthesis in vitro, particularly since 387 
norovirus NS3 has recently been found to associate with vRI-dsRNAs in vRC on 388 
intracellular membranes (34-36). These findings indicate the critical roles of NS3 in 389 
norovirus RNA replication. However, owing to technical limitations, the RNA 390 
remodeling activities of viral proteins have been mainly studied in vitro, and it is 391 
difficult to imagine how the regulation of the structures and functions of vRNAs by 392 
viral RNA helicases/chaperones can be investigated in detail in virus-infected cells. 393 
Future advances in techniques may overcome these barriers and help understand the 394 
mechanism(s) of how the RNA helicase/chaperoning activities of NS3 remodel 395 
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vRNAs at different stages of noroviral life cycle. 396 
Interestingly, we found that the guanidine salt, GuHCl, inhibits both the ATPase 397 
and RNA helix unwinding activities of NV NS3 in a dose-dependent manner (Fig. 9), 398 
similar to the effects of the same compound on enterovirus 2C
ATPase
 (22, 41). Although 399 
previous work found that the ATPase activity of SHV NS3 was not inhibited by 400 
GuHCl (33), our data show that NV NS3 has some difference with SHV NS3 in terms 401 
of ATPase activity. For example, while SHV NS3 has been found to hydrolyze UTP 402 
much less well than ATP (30), NV NS3 exhibited similar hydrolysis efficiency to both 403 
ATP and UTP (Fig. 2A). Moreover, when the concentration of Mg
2+
 is higher than 2 404 
mM, the ATPase activity of NV NS3 was inhibited in a dose-dependent manner (Fig. 405 
2C), while that of SHV NS3 was moderately enhanced (30). It is possible that the 406 
difference between NV NS3 and SHV NS3 in ATPase activity is due to the different 407 
(eukaryotic vs. prokaryotic) expression strategies. 408 
Virus-encoded RNA remodeling proteins, particularly helicases, have long been 409 
considered as valuable targets for antiviral compounds, because they are well 410 
conserved within or even across virus families (57). In particular, enterovirus 2C
ATPase
, 411 
another SF3 viral RNA helicase, has been found to be inhibited by ~1 mM GuHCl, as 412 
is enterovirus replication (22, 42-45). Using a NV replicon as model, our studies 413 
demonstrate that ~1 mM GuHCl can significantly inhibit the replication of HuNoV in 414 
cultured human cells with negligible cell toxicity (Fig. 9). Similarly, GuHCl can 415 
inhibit the replication of poliovirus at the same concentration (22). Guanidines are 416 
ubiquitously present in nature, and are categorized as organic superbases with highly 417 
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basic nature and notable stability, that can function as mediators of specific 418 
non-covalent binding in various catalytic processes (58, 59). Due to their 419 
physicochemical characteristics, guanidine molecules probably bind stably to the 420 
surfaces of viral RNA remodeling proteins, such as enterovirus 2C
ATPase
 and HuNoV 421 
NS3, and may therefore alter their conformations, electrostatic states, and/or 422 
protein-protein/RNA interactions, thereby inhibiting their RNA remodeling activities. 423 
In accordance with this idea, high concentrations of Mg
2+
 (> 2mM) have been found 424 
to inhibit the helix unwinding by either NV NS3 (Fig. 2C) or EV71 2C
ATPase
 (22). 425 
GuHCl is a U.S. FDA-approved small compound drug that has been used to treat the 426 
symptoms of muscle weakness and fatigability associated with Eaton-Lambert 427 
syndrome 428 
(http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&429 
ApplNo=001546) (60, 61). Moreover, guanidine derivatives have attracted 430 
widespread interest for developing drugs against various diseases, and some of them 431 
have been found to be potential antivirals against hepatitis C virus (HCV), human 432 
immunodeficiency virus (HIV), and flaviviruses (21, 58, 59). It is unlikely that 433 
GuHCl can be directly used as an antiviral drug against HuNoV infection due to the 434 
high concentration needed for inhibition of NS3 and NV replication. However, given 435 
the presence of multiple derivative forms of guanidine, the syntheses and screening of 436 
various guanidine derivatives and guanidine-containing compounds may help in the 437 
quest for small molecules that have better inhibitory effects on HuNoV NS3 and 438 
HuNoV replication. 439 
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In conclusion, this study provides the first demonstration of the RNA helicase and 440 
chaperoning activities associated with a norovirus- or calicivirus-encoded protein, and 441 
reveals that NS3 may have a direct function (in concert with the NS7/RdRP) in 442 
norovirus RNA replication. Moreover, it also provides evidence that GuHCl is an 443 
inhibitor of not only the in vitro RNA remodeling activities of NS3 but also the 444 
replication of HuNoV in human cells. Altogether, these findings highlight the 445 
functional significance of NS3 in noroviral life cycle, and shed new light on the 446 
understanding of norovirus replication.  447 
 448 
 449 
 450 
 451 
 452 
 453 
 454 
 455 
 456 
 457 
 458 
 459 
 460 
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MATERIALS AND METHODS 462 
Construction of recombinant baculoviruses, and expression and purification of 463 
recombinant proteins 464 
The generation of pFastBac HTB-MBP has been described previously (26). The 465 
cDNA of NV NS3 (GenBank Accession No. KF039736) was synthesized by Tian Yi 466 
Hui Yuan Biotech Co. (Wuhan, China), and cloned into the vector pFastBac 467 
HTB-MBP. Site-directed mutagenesis was conducted as previously described (26). 468 
The resulting plasmids were subjected to Bac-to-Bac baculovirus system to produce 469 
recombinant proteins. The primers used for NS3 plasmid construction: 470 
forward-GAATTCATGGGCCCCGAGGACCTTGCCAGGGATCTCGTG and 471 
reverse-GTCGACCTACTGGAGTTGGAACTCATCCTGTCTCTCCAT; the primers 472 
for the GK168AA and GK168AA-DD212AA of NS3 are: forward-TGTGGGCCCCC 473 
TGGTATAGCTGCTACCAAG and reverse-GTTCTGCTGCCTTGGTAGCAGCTAT 474 
ACCAG; forward-GCTGTGGGCTGCTTATGGAATGACAAAGAT and reverse-TG 475 
TATCTTTGTCATTCCATAAGCAGCCCAC. 476 
The expression and purification of recombinant MBP alone and MBP-fusion 477 
proteins were conducted using standard procedures as previously described (25, 26). 478 
All purified proteins were quantified by BCA Protein Assay Kit (CWBIO, China) and 479 
stored at -80℃ in aliquots. Proteins were separated on 10% SDS-PAGE and 480 
visualized by Coomassie blue. 481 
 482 
Structural modeling and structural alignment analyses 483 
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The 3D structure of NV NS3 was modeled by submitting its amino acid sequence 484 
to the HMMSTR/Rosetta server [from Robetta, University of Washington 485 
(http://robetta.bakerlab.org/)]. Five models were obtained, and the best one was 486 
chosen as a template based on its score, and assessed by submitting it to the 487 
SWISS-MODEL Server [from Swiss Institute of Bioinformatics and the Biozentrum, 488 
University of Basel, Switzerland (http://siwssmodel.expasy.org)]. The Figure of the 489 
modeled NS3ΔN and the structural alignments with SV40 LTag (PDB ID code 4GDF), 490 
HPV18 E1 (PDB ID code 1TUE), and AAV2 Rep40 (PDB ID code 1U0J) were 491 
generated from coordinate files using PyMOL version 1.1 (DeLano Scientific LLC, 492 
Southern San Francisco, CA).   493 
 494 
NTPase assay 495 
NTPase activities were determined via measuring the released inorganic 496 
phosphate during NTP hydrolysis using a direct colorimetric assay according to our 497 
standard procedures as previously described (26). The concentrations of released 498 
inorganic phosphate were determined by matching the A620 in a known inorganic 499 
phosphate curve. All of the results given with this quantitative assay were averages of 500 
three independently repeated experiments. 501 
 502 
Preparation of oligonucleotide helix substrates 503 
The nucleic acid helix substrates were prepared according to our standard 504 
procedures as previous described (22). In brief, RNA, DNA or RNA-DNA hybrid 505 
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helix substrates were prepared by annealing two complementary nucleic acid strands, 506 
of which one strand was labeled at 5´-end with HEX, while the other was unlabeled. 507 
The two strands were mixed at a proper ratio in a 10 μl reaction mixture containing 508 
25mM HEPES-KOH (pH 8.0) and 25mM NaCl. And the mixture was then heated to 509 
95℃ for 5 min and gradually cooled to 25℃ to produce helical duplexes. All 510 
HEX-labeled DNA and RNA strands were purchased from Takara (Dalian, China), 511 
unlabeled DNA strands were synthesized by Invitrogen, and unlabeled RNA strands 512 
were in vitro transcribed using T7 RNA polymerase (Promega, Madison, WI). The in 513 
vitro transcribed RNA strands were purified by Poly-Gel RNA Extraction Kit (Omega 514 
bio-tek, Guangzhou, China) according to the manufacturer’s instructions. The 515 
standard RNA helix substrate with both 5´ and 3´ protrusion was annealed using 516 
RNA1 and RNA2, the DNA helix substrate was annealed using DNA2 and DNA3, the 517 
RNA*-DNA hybrids was annealed using RNA1 and DNA1, the DNA*-RNA hybrids 518 
was annealed using DNA1 and RNA3, the 3´ protruded RNA helix was annealed 519 
using RNA1 and RNA4, and the 5´ protruded RNA helix was annealed using RNA1 520 
and RNA5. All oligonucleotides used in this study are listed in Table 1. 521 
 522 
Helix unwinding and RNA strand hybridization assays 523 
Helix unwinding assay was performed according to our standard procedures as 524 
previously described (25). The reaction mixtures were electrophoresed on 15% 525 
native-PAGE gels and then scanned with a Typhoon 9500 imager (GE Healthcare, 526 
Piscataway, NJ).  527 
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The RNA hybridization assay was carried out according to our standard 528 
procedures as previously described (25). In brief, the indicated amount of protein, 0.2 529 
pmol HEX-labeled stem-loop-structured RNA strand, and 0.2 pmol unlabeled 530 
stem-loop-structured RNA strand were added to reaction buffer and incubated for 1 h 531 
or the indicated time. The sequences of the stem-loop-structured RNA strands are 532 
given in Fig. 7B. The reaction products were resolved on 15% native-PAGE gels, 533 
followed by scanning by Typhoon 9500 imager (GE Healthcare, Piscataway, NJ). 534 
 535 
In vitro RdRP assays 536 
The vRNA template was in vitro transcribed by T7 RNA polymerase as described 537 
above. The (-)-vRNA template contains 1-400 nts of 3´-end HuNoV (-)-RNA, which 538 
is complementary to 5´-end 400 nts of HuNoV (+)-RNA. The transcribed product was 539 
purified by Poly-Gel RNA Extraction Kit (Omega bio-tek, Guangzhou, China) 540 
according to the manufacturer’s instruction. The cDNA of HuNoV NS7/RdRP 541 
(GenBank Accession No. KR904238) was amplified by PCR from full-length 542 
GII.4-Sydney HuNoV cDNA, which was generously provided by Dr. Linqing Zhao 543 
(Capital Institute of Pediatrics, Beijing, China), and cloned into the vector the vector 544 
pMAl-c2X-MBP (primers: forward-GGATCCATGGGAGGAAACACTGTCATATG 545 
TGCCACCCAG and reverse-GTCGACTCACTCGACGCCATCTTCATTCACAAA 546 
ACTGGG). The recombinant MBP-fusion NS7/RdRP was purified as described 547 
above. The RdRP assay was performed as previously described with minor 548 
modification. In brief, indicated amounts of MBP-NS3 were included in 10 μl 549 
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reactions containing 50mM HEPES-KOH (pH7.5), 12.5mM KCl, 5mM MgCl2, 5mM 550 
DTT, 20U RNasin (Promega), and 5mM NTPs. MBP-NS3 was included in the 551 
reaction mix with or without 10 pmol NS7/RdRP at 30℃ for the indicated time. After 552 
that, the reaction was terminated by 2×loading buffer (20% 10×MOPS running buffer, 553 
10% glycerol, 50% formamide, 20% formaldehyde and 0.05% bromophenol blue), 554 
and then denatured at 65℃ for 10min. The samples were electrophoresed on 1.5% 555 
agarose-formaldehyde denaturing gels, and transferred onto N+ nylon membranes 556 
(Roche). The RdRP products were detected via Northern blots that were performed 557 
according to our standard procedures (62). The probe for Northern blots was listed in 558 
Table 1. 559 
 560 
Assessment of GuHCl treatment in HuNoV-replicon harboring cells 561 
A baby hamster kidney cell line harbouring the NV replicon, provided by Dr. 562 
Kim Green (National Institutes of Health, Bethesda, MD), was used as a source of 563 
viral VPg-linked RNA (63). Total RNA was isolated from the BHK-NV replicon 564 
containing cell line and transfected into HGT-1 (64). The transfected cells were placed 565 
under selection using 1mg/ml of G418 and clonal populations were generated by 566 
limiting dilution. The levels of viral RNA determined by qRT-PCR as described and a 567 
single clone selected for future use, referred to as HGT-NV.  568 
To examine the effect of GuHCl on NV replication, HGT-NV cells were seeded in 569 
96-well plate at 1,000 cells per well without G418. HGT-NV cells were immediately 570 
incubated with media containing various levels of GuHCl or 2CMC as a control. Cells 571 
were incubated at 37°C in 5% CO2 for 3 days. The effect of GuHCl treatment on 572 
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HuNoV replicon RNA was then evaluated by qRT-PCR as described (65) and western 573 
blot using rabbit polyclonal antisera to norovirus NS3. In addition, the effect of 574 
GuHCl on cell viability was determined using CellTiter-Blue (Promega) according to 575 
the manufacturer’s instructions. 576 
 577 
 578 
 579 
  580 
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FIGURE LEGENDS 777 
Fig. 1. Norovirus NS3 is similar with other virus-encoded SF3 helicases in 778 
consensus motifs and protein structures. (A) The genomic RNA of norovirus is 779 
depicted, which contains three ORFs (1, 2, and 3). The 5’ proximal ORF1 encodes a 780 
polyprotein that is subsequently self-cleaved into six nonstructural proteins (NS1/2, 781 
NS3, NS4, NS5/VPg, NS6
Pro
, and NS7/RdRP) by viral protease NS6
Pro
. The ORF2 782 
and ORF3 encode structural proteins VP1 and VP2, respectively. (B) Sequence 783 
alignments of the helicase core domains of NV NS3 and other SF3 viral helicases, 784 
including EV71 2C
ATPase
, SV40 LTag, HPV18 E1, and AAV2 Rep40. The SF3 785 
consensus motifs A, B, and C were indicated. (C) The structure of NV NS3 without its 786 
N-terminal domain (NS3ΔN) was predicted by the HMMSTR/Rosetta server. NS3ΔN 787 
containing the middle helicase core (HC) domain and the C-terminal domain (CTD) is 788 
shown in green. The SF3 motifs A, B, and C are indicated and highlighted in red. 789 
(D-F) Structural alignments of NV NS3ΔN (green) and SV40 LTag, HPV18E1, or 790 
AAV2 Rep40 (cyan). The N-terminal domain of E2 binding to HPV18 E1 is shown in 791 
brown. The SF3 motifs A, B, and C of these viral helicases are highlighted in blue.  792 
 793 
Fig. 2. NV NS3 has NTPase activity. (A) MBP-NS3 was reacted with the indicated 794 
NTP. The NTPase activity was measured as nanomoles of released inorganic 795 
phosphate. (B-D) The NTPase activity of MBP-NS3 was determined at the indicated 796 
concentrations of ATP (B), at the indicated concentrations of Mg
2+
 (C), or at the 797 
indicated pH (D). For (B and C), the MBP alone was used as the negative control. For 798 
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(A-D), error bars represent standard deviation (SD) values from three separate 799 
experiments. 800 
 801 
Fig. 3. NV NS3 has nucleic acid helix unwinding activity. (A) The standard 802 
RNA/RNA helix (R*/R substrate) is illustrated in the upper panel. 0.1 pmol R*/R 803 
substrate was reacted with 20 pmol each indicated protein. Non-boiled reaction 804 
mixture (lane 1) and the reaction mixture with MBP alone (lane 3) were used as 805 
negative controls, boiled reaction mixture (lane 2) and the reaction mixture with 806 
purified MBP-fusion EV71 2C
ATPase
 (lane 5) were used as positive controls. (B-D) 807 
DNA/DNA helix (D*/D substrate), DNA/RNA hybrid helix (D*/R), and RNA/DNA 808 
hybrid helix (R*/D) are illustrated in each upper panel. 0.1 pmol of each indicated 809 
substrate was reacted with 20 pmol each indicted protein. For (B-D), lane 1, 810 
non-boiled reaction mixture; lane 2, boiled reaction mixture; lane 3, reaction mixture 811 
with purified MBP-fusion NS3; lane 4, reaction mixture with purified MBP-fusion 812 
EV71 2C
ATPase
. The helix unwinding was detected via gel electrophoresis and 813 
scanning on a Typhoon 9500 imager. Asterisks indicate the HEX-labeled strands.  814 
 815 
Fig. 4. Biochemical characterization of RNA helix unwinding activity of NV NS3. 816 
(A) Illustration of the standard RNA helix (R*/R) substrate. (B-D) 0.1 pmol R*/R 817 
substrate was reacted with 20 pmol MBP-NS3 in the absence or presence of 818 
individual NTP (B), increasing concentrations of Mg
2+
 (C), or different pH values (D) 819 
as indicated. Non-boiled (lane 1) or boiled (lane 2) reaction mixture was used as 820 
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negative or positive control. Asterisks indicate the HEX-labeled strands. The helix 821 
unwinding activity was detected via gel electrophoresis and scanning on a Typhoon 822 
9500 imager. 823 
 824 
Fig. 5. NV NS3 unwinds RNA helix in a bidirectional manner. (A and B) 825 
Schematic illustration of the RNA helix substrate with the 5’ single-stranded 826 
protrusion (A) or 3’ single-stranded protrusion (B). Asterisks indicate the 827 
HEX-labeled strands. (C) MBP-NS3 (20 pmol) was incubated with 5’ single-stranded 828 
protruded (lane 3) or 3’ single-stranded protruded (lane 6) RNA helix substrate (0.1 829 
pmol). Non-boiled (lanes 1 and 4) or boiled reaction mixtures (lanes 2 and 5) were 830 
used as negative or positive controls. (D and E) MBP-NS3 (20 pmol) was reacted 831 
with 5’-protruded (D) or 3’-protruded RNA helix substrate (E) in the presence of 832 
indicated concentrations of ATP. The helix unwinding was detected as described in 833 
Fig. 3. 834 
 835 
Fig. 6. The SF3 motif A is critical for the helicase activity of NV NS3. (A) Amino 836 
acids sequence alignment of NV NS3, SHV NS3, and MNV NS3. The SF3 consensus 837 
motifs A, B, and C were indicated. (B) The standard RNA helix (R*/R) substrate (0.1 838 
pmol) was reacted with 20 pmol wild-type (WT) (lane 4), GK168AA (lane 5), or 839 
GK168AA-DD212AA (lane 6) MBP-NS3. Non-boiled reaction mixture (lane 1) and 840 
the reaction mixture with MBP alone addition (lane 3) were used as negative controls; 841 
the boiled reaction mixture (lane 2) was used as positive control. (C) The standard 842 
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RNA helix (R*/R) substrate (0.1 pmol) was reacted with 20 pmol GK168AA mutant 843 
MBP-NS3 in the presence of indicated concentrations of ATP. For (B and C), asterisks 844 
indicate the HEX-labeled strands. 845 
 846 
Fig. 7. NV NS3 has RNA chaperoning activity to destabilize structured RNA 847 
strands and promote annealing. (A) The standard RNA helix (R*/R) substrate (0.1 848 
pmol) was reacted with 20 pmol MBP-NS3 in the absence or presence of 5 mM ATP 849 
or ATP analog (AMP-PNP) as indicated. Lane 1, non-boiled reaction mixture; lane 2,  850 
boiled reaction mixture; lane 3, the reaction mixture with MBP-NS3 in the absence of 851 
ATP; lanes 4-5, the reaction mixture with MBP-NS3 in the presence of AMP-PNP or 852 
ATP. (B) Schematic illustrations of the stem-loop structures of the two complementary 853 
42-nt RNA strands. Asterisk indicates the HEX-labeled strand. (C) The two strands 854 
were 1:1 mixed (0.1 pmol each) and reacted with indicated amount of MBP-NS3. (D) 855 
The hybridization assay as in (C) was conducted in the absence (lanes 3-6) or 856 
presence (lanes 7-10) of 20 pmol MBP-NS3 for indicated reaction times. For (C and 857 
D), the pre-annealed (lane 1) or boiled (lane 2) strands were used as positive or 858 
negative control, respectively. The hybridized and free strands are indicated. 859 
 860 
Fig. 8. NV NS3 facilitates noroviral RNA synthesis in vitro. (A) Schematic 861 
illustration of the experimental procedures. (B and D) The in vitro transcribed NV 862 
3’-end 1-400 nts of (-)-vRNA template was incubated with 10 pmol recombinant 863 
NS7/RdRP and NTP mix in the absence or presence of 10 pmol MBP-NS3 (B) or 864 
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MBP-NS3GK168AA (D) at 30 °C for 30, 60 or 90 min as indicated. The reaction 865 
products were detected by Northern blots. (C and E) The synthesized (+)-RNA 866 
products in (B and D) were quantified via Bio-Rad Quantity One software. The 867 
relative RNA production was determined by comparing the level of RNA products in 868 
presence of MBP-NS3 at each indicated time point with that in the absence of NS3 at 869 
30 min (lane 2). The error bars represent SD values from three separate experiments. 870 
 871 
Fig. 9. GuHCl inhibits the biochemical activities of NV NS3. (A) The NTPase 872 
activity of MBP-NS3 was measured as nanomoles of released inorganic phosphate in 873 
the presence of indicated concentrations (0-10 mM) of GuHCl. MBP alone was used 874 
as the negative control. (B) The standard RNA helix (R*/R) substrate is illustrated in 875 
the upper panel. 0.1 pmol R*/R substrate was reacted with 20 pmol MBP-NS3 in the 876 
presence of indicated concentrations (0-10 mM) of GuHCl. Native (lane 1) or boiled 877 
(lane 2) reaction mixture was used as negative or positive control, respectively. The 878 
helix unwinding was detected via gel electrophoresis and scanning on a Typhoon 879 
9500 imager. Asterisk indicates the HEX-labeled strand. (C) The unwinding activities 880 
under different GuHCl concentrations were plotted as a percentage of the released 881 
RNA from the total RNA helix substrate (Y-axis) at each indicated GuHCl 882 
concentration (X-axis) via Bio-Rad Quantity One software. The error bars represent 883 
standard deviation values from three separate experiments. (D) The two strands in Fig. 884 
7B were 1:1 mixed (0.1 pmol each) and reacted with 10 pmol MBP-NS3 for 30 min in 885 
presence of different concentrations of GuHCl in the absence of NTP. The 886 
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hybridization of the two strand was detected via gel electrophoresis and scanning on a 887 
Typhoon 9500 imager. The pre-annealed (lane 1) or boiled (lane 2) reaction mixture 888 
was used as positive or negative control, respectively. The hybridized and free strands 889 
are indicated. (E) The effect of GuHCl or 2-CMC on Norwalk virus RNA levels was 890 
determined by examining the impact on NV replicon RNA levels in HGT-NV cells 891 
following 3 days of treatment. HGT-NV cells were treated with the indicated levels of 892 
either GuHCl or 2-CMC and the levels of viral RNA calculated as a percentage of 893 
mock-treated control. (F) HGT-NV cells were treated as in (D) and the number of 894 
viable cells were determined. The cell viability was calculated as a percentage of 895 
mock-treated control. The error bars represent SD (n=3). Statistical significance was 896 
determined using an unpaired t-test. The experiment was repeated at least two 897 
independent times, with one representative data set presented. 898 
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TABLE 909 
Table 1 List of oligonucleotides. 910 
Oligonuleotide Sequence(5’-3’) 
RNA1 *CAUUAUCGGAUAGUGGAACCUAGCUUCGACUAUCGGAUAAUC 
RNA2 AAUAAAGAUUAUCCGAUAGUCGAAGCUAGGUUCCACUAUCCGAUA
AUGAAAUAA 
RNA3 UGUAGUGCUGCCAUGGUGUGGUGGUGGUGGUUGUGGUGGAGCUAC
GAAC 
RNA4 GAUUAUCCGAUAGUCGAAGCUAGGUUCCACUAUCCGAUAAUGAAA
UAA 
RNA5 AAUAAAGAUUAUCCGAUAGUCGAAGCUAGGUUCCACUAUCCGAUA
AUG 
DNA1 AATAAAGATTATCCGATAGTCGAAGCTAGGTTCCACTATCCGATAATGA
AATAA 
DNA2 *CACCACAACCACCACCACCACACCATGG 
DNA3 TGTAGTGCTGCCATGGTGTGGTGGTGGTGGTTGTGGTGGAGCTACGA
AC 
Probe GUGAAUGAAGAUGGCGUCUAACGGCGCUUCCGCUGCCGCUGUUGC
CAACAGCAACAACGACAUCGCAAAAUCUUCAAGUGACGGUGUGUU
UUCUAACAUGGCUGUCACUUUUAAGCGGGCCCUCGGGGCG 
CGGCCUAAAC 
*indicate HEX labeled strand. 911 
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